Structure−Activity Relationships of Ring C-Secotaxoids. 1. Acylative Modifications-Reference-Cited by-同舟云学术

Structure−Activity Relationships of Ring C-Secotaxoids. 1. Acylative Modifications

Published:2003-10-22 Issue:2 Volume:67 Page:184-188
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Appendino Giovanni¹,Bettoni Piergiorgio¹,Noncovich Alain¹,Sterner Olov¹,Fontana Gabriele¹,Bombardelli Ezio¹,Pera Paula¹,Bernacki Ralph J.¹

Affiliation:

1. Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche, Università del Piemonte Orientale, Viale Ferrucci 33, 28100 Novara, Italy, Department of Organic and Bioorganic Chemistry, Lund University, P.O. Box 124, 221 00 Lund, Sweden, Indena S.p.A. Viale Ortles 12, 20139 Milano, Italy, and Department of Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/np0303456

Reference23 articles.

1. Synthesis and evaluation of C-seco paclitaxel analogues

2. Synthesis of modified baccatins via an oxidation-reduction protocol

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug metabolism and pharmacokinetic diversity of Taxus medicinal compounds;Taxaceae and Cephalotaxaceae;2021

2. Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Taxus-based Drug Development;Current Drug Metabolism;2018-10-02

3. Phytochemical composition and antioxidant activities of different aerial parts extracts of Ferula communis L.;Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology;2018-05-02

4. Plant-Derived Natural Products Research in Drug Discovery;Natural Products in Chemical Biology;2012-05-14

5. Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III β-tubulin;Bioorganic & Medicinal Chemistry Letters;2009-06